Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American Countries

Simple item page
dc.contributor.authorAndrés Pichón-Rivière
dc.contributor.authorUlises Ángeles Garay
dc.contributor.authorFederico Augustovski
dc.contributor.authorCarlos Vallejos
dc.contributor.authorLeandro Huayanay
dc.contributor.authorM.D.P. Navia
dc.contributor.authorA. Rodríguez
dc.contributor.authorCharles William Cavalcante De Oliveira
dc.contributor.authorCicera Andrade
dc.contributor.authorJefferson Antonio Buendía
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T17:13:43Z
dc.date.available2026-03-22T17:13:43Z
dc.date.issued2013
dc.identifier.doi10.1016/j.jval.2013.08.1930
dc.identifier.urihttps://doi.org/10.1016/j.jval.2013.08.1930
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/62928
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofValue in Health
dc.sourceInstituto de Efectividad Clínica y Sanitaria
dc.subjectPer capita
dc.subjectTrastuzumab
dc.subjectQuality-adjusted life year
dc.subjectActuarial science
dc.subjectWillingness to pay
dc.subjectMedicine
dc.subjectEconomics
dc.subjectCost effectiveness
dc.subjectEconometrics
dc.titleImplications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American Countries
dc.typearticle

Files

Collections

Artículo Científico Publicado